Services search (in the department)
| Illness | Number of cases |
|---|---|
| Malignant neoplasm of prostate (C61) | not specified |
| Malignant neoplasm of bladder - Malignant neoplasm of posterior wall of bladder (C67.4) | not specified |
| Malignant neoplasm of bladder - Malignant neoplasm of ureteric orifice (C67.6) | not specified |
| Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) | not specified |
| Cystitis (N30.2) | not specified |
| Urethral stricture (N35.8) | not specified |
| Hyperplasia of prostate (N40) | not specified |
| Redundant prepuce phimosis and paraphimosis (N47) | not specified |
| Other symptoms and signs involving the urinary system (R39.1) | not specified |
| Treatment | Number |
|---|---|
| Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) | 7 |
| Injection or administration of medicines into the urinary bladder (8-132.3) | 6 |
| Taking a tissue sample (biopsy) of the male reproductive organs through the rectum (1-464.00) | 0 |
| Examination of the urethra and the urinary bladder by endoscopy (1-661) | 0 |
| Surgical creation of a connection between the urinary bladder and skin of the abdomen for artificial urinary drainage (5-572.1) | 0 |
| Surgical dilatation of the urethral opening (5-581.0) | 0 |
| Surgical dilatation of the urethral opening (5-581.1) | 0 |
| Surgical removal or destruction of diseased tissue in the urethra (5-582.0) | 0 |
| Surgical incision into diseased tissue in the urethra, with access through the urethra (5-585.1) | 0 |
| Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) | 0 |
Department key: 2200
Inpatient department
| Bezeichnung | |
| Teilnahme externe Qualitätssicherung | 0 |
| No. | Explanation |
|---|---|
| CQ31 | |
| CQ01 |
| Number | Group |
|---|---|
| 60 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
| 59 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
| 55 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
| No. | Training in other healing professions | Comment |
|---|---|---|
| HB17 | Auxiliary nurse (m/f) | |
| HB15 | Anaesthesia technical assistant (m/f) | |
| HB19 | Nursing professionals | |
| HB07 | Surgical technical assistant (m/f) |
0173-8984349 Gisela Nußbaumer
Patientenfürsprecherin
Phone:
0173
-8984349-
Mail:
moc.soipelksa@lednak
Lydia Maurer
Leitung Qualitätsmanagement und Risikomanagement
Phone:
07275
-71-2600
Mail:
moc.soipelksa@reruam.l